Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Post by StkMrtGmron Mar 07, 2019 2:21pm
38 Views
Post# 29456884

Does anyone know why Compass said no way after DD

Does anyone know why Compass said no way after DDWhatever happened to this deal? &nbsp;Why did Compass say no way we are not dealing with this sh!tshow?<br /> <br /> <span style="caret-color: rgb(0, 0, 0); color: rgb(0, 0, 0); font-size: 16px; -webkit-text-size-adjust: auto; font-family: Arial, Helvetica, sans-serif;">CALGARY, Alberta, May 03, 2018 (GLOBE NEWSWIRE) -- 10330698 Canada Ltd. (dba Compass Cannabis Clinic, or &quot;the Company&quot;) has announced today that, pursuant to the terms of the binding letter agreement dated April 18, 2018 and between the Company and Isodiol International Inc. (&quot;Isodiol&quot;), it has terminated the proposed transaction whereby Isodiol would, after the completion of the transaction, have acquired 19.9% of the issued and outstanding shares of Compass. Accordingly, the transaction between the parties will not be proceeding.</span>

Per the agreement, Isodiol will issue a total of $4,000,000 CDN, with $2,000,000 paid in cash and $2,000,000 paid in stock for the 19.9% of equity acquisition, subject to 36-month escrow.

Is Isodiol stock not worth the paper it is printed on?
Bullboard Posts